A comparative evaluation of factors influencing osteoinductivity among scaffolds designed for bone regeneration

Tissue Engineering - Part A

Volumn 19, Issue 15-16, 2013, Pages 1764-1772

  Hsu, Erin L ^a,b   Ghodasra, Jason H ^a   Ashtekar, Amruta ^a   Nickoli, Michael S ^a   Lee, Sungsoo S ^b   Stupp, Samuel I ^a,b   Hsu, Wellington K ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION; CERAMIC MATERIALS; GENE EXPRESSION; NANOFIBERS;

BINDING AND RELEASE; BONE MORPHOGENETIC PROTEIN-2; BONE REGENERATION; COMPARATIVE EVALUATIONS; NANOFIBER SCAFFOLD; OSTEOINDUCTIVITY; SIGNIFICANT DIFFERENCES; SYNTHETIC SCAFFOLDS;

SCAFFOLDS (BIOLOGY);

BONE MORPHOGENETIC PROTEIN 2; NANOFIBER; TISSUE SCAFFOLD;

BONE REGENERATION; CELL ADHESION; CELL LINE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; HUMAN; METABOLISM; OSTEOBLAST; PHYSIOLOGY; TISSUE SCAFFOLD; ARTICLE;

BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CELL ADHESION; CELL LINE; CELL PROLIFERATION; HUMANS; NANOFIBERS; OSTEOBLASTS; TISSUE SCAFFOLDS;

EID: 84879680565     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0711     Document Type: Article

References (33)

1. Dawson, J.I., and Oreffo, R.O. Bridging the regeneration gap: stem cells, biomaterials and clinical translation in bone tissue engineering. Arch Biochem Biophys 473, 124, 2008.
2. Dimar, J.R., 2nd, Glassman, S.D., Burkus, J.K., et al. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis. J Bone Joint Surg Am 91, 1377, 2009.
3. Summers, B.N., and Eisenstein, S.M. Donor site pain from the ilium. A complication of lumbar spine fusion. J Bone Joint Surg Br 71, 677, 1989.
4. Barriga, A., D?́az-de-Rada, P., Barroso, J.L., et al. Frozen cancellous bone allografts: positive cultures of implanted grafts in posterior fusions of the spine. Eur Spine J 13, 152, 2004.
5. Brower, R.S., and Vickroy, N.M. A case of psoas ossification from the use of BMP-2 for posterolateral fusion at L4-L5. Spine 33, E653, 2008.
6. McClellan, J.W., Mulconrey, D.S., Forbes, R.J., et al. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2). J Spinal Disord Tech 19, 483, 2006.
7. Muchow, R.D., Hsu, W.K., and Anderson, P.A. Histopathologic inflammatory response induced by recombinant bone morphogenetic protein-2 causing radiculopathy after transforaminal lumbar interbody fusion. Spine J 10, E1, 2010.
8. Pradhan, B.B., Bae, H.W., Dawson, E.G., et al. Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2. Spine 31, E277, 2006.
9. Vaidya, R. Transforaminal interbody fusion and the ''off label'' use of recombinant human bone morphogenetic protein- Spine J 9, 667, 2009.
10. Vaidya, R., Sethi, A., Bartol, S., et al. Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions. J Spinal Disord Tech 21, 557, 2008.
11. Wong, D.A., Kumar, A. Jatana, S., et al. Neurologic impairment from ectopic bone in the lumbar canal: A potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J 8, 1011, 2008.
12. Sys, J., Weyler, J., Van Der Zijden, T., et al. Platelet-rich plasma in mono-segmental posterior lumbar interbody fusion. Eur Spine J 20, 1650, 2011.
13. Jenis, L.G., and Banco, R.J. Efficacy of silicate-substituted calcium phosphate ceramic in posterolateral instrumented lumbar fusion. Spine 35, E1058, 2010.
14. Epstein, N. An analysis of noninstrumented posterolateral lumbar fusions performed in predominantly geriatric patients using lamina autograft and beta tricalcium phosphate. Spine J 8, 882, 2008.
15. Brandoff, J.F., Silber, J.S., and Vaccaro, A.R. Contemporary alternatives to synthetic bone grafts for spine surgery. Am J Orthop 37, 410, 2008.
16. Willie, B.M., Petersen, A., Schmidt-Bleek, K., et al. Designing biomimetic scaffolds for bone regeneration: why aim for a copy of mature tissue properties if nature uses a different approach. Soft Matter 6, 4976, 2010.
17. Hartgerink, J.D., Beniash, E., and Stupp, S.I. Self-assembly and mineralization of peptide-amphiphile nanofibers. Science 294, 1684, 2001.
18. Mata, A., Geng, Y., Henrikson, K.J., Aparicio, C., et al. Bone regeneration mediated by biomimetic mineralization of a nanofiber matrix. Biomaterials 31, 6004, 2010.
19. Zhu, W., Boachie-Adhei, O., Rawlins, B.A., et al. A novel regulatory role for stromal derived factor-1signaling in bone morphogenetic protein-2 osteogenic differentiation of mesenchymal C2C12 cells. J Biol Chem 282, 18676, 2007.
20. Biggs, M.J.P., Richards, R.G., Gadegaard, N., et al. Interactions with nanoscale topography: Adhesion quantification and signal transduction in cells of osteogenic and multipotent lineage. J Biomed Mater Res Part A 91A, 195, 2008.
21. Seebach, C., Schultheiss, J., Wilhelm, K., et al. Comparison of six bone-graft substitutes regarding to cell seeding efficiency, metabolism and growth behaviour of human mesenchymal stem cells (MSC) in vitro. Injury 41, 731, 2010.
22. Fiedler, J., Rö derer, G., Gü nther, K.P., et al. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 87, 305, 2002.
23. King, W.J., and Krebsbach, P.H. Growth factor delivery: How surface interactions modulate release in vitro and in vivo. Adv Drug Deliv Rev 64, 1239, 2012.
24. Takahashi, Y., Yamamoto, M., and Tabata, Y. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and b-tricalcium phosphate. Biomaterials 26, 4856, 2005.
25. Helm, G.A., Sheehan, J.M., Sheehan, J.P., et al. Utilization of type I collagen gel, demineralized bone matrix, and bone morphogenetic protein-2 to enhance autologous bone lumbar spinal fusion. J Neurosurg 86, 93, 1997.
26. Zhang, S., Doschak, M.R., and Uludag, H. Pharmacokinetics and bone formation by BMP-2 entrapped in polyethyleniminecoated albumin nanoparticles. Biomaterials 30, 5143, 2009.
27. Kortesidis, A., Zannettino, A., Isenmann, S., et al. Stromalderived factor-1 promotes growth, survival, and development of human bone marrow stromal stem cells. Blood 105, 3793, 2005.
28. Fong, E.L.S., Chan, C.K., and Goodman, S.B. Stem cell homing in musculoskeletal injury. Biomaterials 32, 395, 2011.
29. Granero-Molto, F., Weis, J.A., Miga, M.I., et al. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells 27, 1887, 2009.
30. Wynn, R.F., Hart, C.A., Corradi-Perini, C., et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104, 2643, 2004.
31. Hosogane, N., Huang, Z., Rawlins, B.A., et al. Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells. Int J Biochem Cell Biol 42, 1132, 2010.
32. Kitaori, T., Ito, H., Schwarz, E.M., et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 60, 813, 2009.
33. Miron, R.J., and Zhang, Y.F. Osteoinduction: A review of old concepts with new standards. J Dental Res 91, 736, 2012.